Therapeutic Asset Ratings
210 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
ngm707
Glioblastoma
NGM Biopharmaceuticals, Inc
P1/2
CC
(41)
Nms-03305293
Glioblastoma
Nerviano Medical Sciences
P1/2
CC
(41)
Olaptesed Pegol
Glioblastoma
TME Pharma AG
P1/2
CC
(41)
Prochlorperazine
Glioblastoma
SignPath Pharma, Inc.
P1/2
CC
(41)
rz-001
Glioblastoma
Rznomics, Inc.
P1/2
CC
(41)
st101
Glioblastoma
Sapience Therapeutics
P1/2
CC
(41)
Verteporfin
Glioblastoma
Emory University
P1/2
CC
(41)
vrt106
Glioblastoma
Guangzhou Virotech Pharmaceutical Co., Ltd.
P1/2
CC
(41)
Zofran
Glioblastoma
SignPath Pharma, Inc.
P1/2
CC
(41)
asp8374
Glioblastoma
Dana-Farber Cancer Institute
P1
CC
(40)
bi 907828
Glioblastoma
Boehringer Ingelheim
P1
CC
(40)
CV09050101 mRNA vaccine
Glioblastoma
CureVac
P1
CC
(40)
G 207
Glioblastoma
M.D. Anderson Cancer Center
P1
CC
(40)
Iti-1001
Glioblastoma
Immunomic Therapeutics, Inc.
P1
CC
(40)
prt3645
Glioblastoma
Prelude Therapeutics
P1
CC
(40)
ro7428731
Glioblastoma
Hoffmann-La Roche
P1
CC
(40)
plx038
Glioblastoma
National Cancer Institute (NCI)
P1/2
CC
(40)
bgb324
Glioblastoma
BerGenBio ASA
P1
C
(39)
131i-ipa
Glioblastoma
Telix Pharmaceuticals (Innovations) Pty Limited
P1
C
(37)
²¹²pb-dotam-grpr1
Glioblastoma
Orano Med Theranostics, SAS
P1
C
(37)
Abbv-637
Glioblastoma
Memorial Sloan Kettering Cancer Center
P1
C
(37)
Abexinostat
Glioblastoma
University of Nebraska
P1
C
(37)
Ad5-yCD
Glioblastoma
Henry Ford Health System
P1
C
(37)
ad5-ycd/muttksr39rep-adp adenovirus
Glioblastoma
Henry Ford Health System
P1
C
(37)
Autologous Dcs Derived From Pbmc Loaded With Rna Encoding The Human Cmv Matrix Protein Pp65-Fllamp Plus Gm-Csf
Glioblastoma
University of Florida
P1
C
(37)
Showing 126 to 150 of 210 assets
Previous
Page 6 of 9
Next
